99 related articles for article (PubMed ID: 5327493)
1. Chemotherapy in ovarian malignancy: tumor sensitivity testing.
Riggs JA; Jackson LG; Weiss AJ; Farell DM; Traiman R
Obstet Gynecol; 1966 Jun; 27(6):869-74. PubMed ID: 5327493
[No Abstract] [Full Text] [Related]
2. Predicting ovarian tumor response.
Foubister V
Drug Discov Today; 2005 Mar; 10(6):380-1. PubMed ID: 15808813
[No Abstract] [Full Text] [Related]
3. Second Joint Working Conference: National Cancer Institute Chemotherapy Program. Working session report: clinical trials.
Carbone PP
Cancer Chemother Rep 3; 1972 May; 3(1):73-5. PubMed ID: 4559007
[No Abstract] [Full Text] [Related]
4. Chemotherapy for ovarian cancer: an evidence-based approach.
Geisler JP; Manahan KJ; Wiemann MC
Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal chemotherapy in ovarian cancer.
Hofstra LS; de Vries EG; Mulder NH; Willemse PH
Cancer Treat Rev; 2000 Apr; 26(2):133-43. PubMed ID: 10772970
[TBL] [Abstract][Full Text] [Related]
6. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
7. The promise and perils of 'targeted therapy' of advanced ovarian cancer.
Markman M
Oncology; 2008; 74(1-2):1-6. PubMed ID: 18536523
[TBL] [Abstract][Full Text] [Related]
8. [Initial treatment for ovarian cancer].
Suzuki M; Fujiwara H; Takei Y
Gan To Kagaku Ryoho; 2009 Feb; 36(2):224-9. PubMed ID: 19263611
[No Abstract] [Full Text] [Related]
9. [Clinical evaluation of the effect of chemotherapy in ovarian neoplasms].
Uher M; Slot E
Cesk Gynekol; 1971 Sep; 36(7):433-4. PubMed ID: 5110666
[No Abstract] [Full Text] [Related]
10. Investigational agents for epithelial ovarian cancer.
Muggia F; Kosloff R
Expert Rev Anticancer Ther; 2005 Oct; 5(5):855-68. PubMed ID: 16221055
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal chemotherapy for ovarian cancer: overview and perspective.
Rao G; Crispens M; Rothenberg ML
J Clin Oncol; 2007 Jul; 25(20):2867-72. PubMed ID: 17617517
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal chemotherapy in the treatment of ovarian cancer.
Kavanagh JJ
J Surg Oncol; 2007 Dec; 96(7):541-2. PubMed ID: 17654524
[No Abstract] [Full Text] [Related]
13. Is single-agent chemotherapy acceptable in platinum-sensitive relapsed ovarian cancer?
Abou-Jawde RM; Oberoi SS
J Clin Oncol; 2008 May; 26(15):2602-3; author reply 2603. PubMed ID: 18487582
[No Abstract] [Full Text] [Related]
14. Second-line chemotherapy of epithelial ovarian cancer.
Markmon M
Expert Rev Anticancer Ther; 2003 Feb; 3(1):31-6. PubMed ID: 12597347
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer and the battle of the specialists.
McGuire WP
J Clin Oncol; 2007 Aug; 25(23):3554-5; author reply 3557-8. PubMed ID: 17687166
[No Abstract] [Full Text] [Related]
16. New, expanded, and modified use of approved antineoplastic agents in ovarian cancer.
Markman M
Oncologist; 2007 Feb; 12(2):186-90. PubMed ID: 17296814
[TBL] [Abstract][Full Text] [Related]
17. Re: Dr. Markman's editorial "Why overall survival should not be the sole valid primary endpoint of phase 3 ovarian cancer chemotherapy trials" Gynecol. Oncol. 106(2); 279-81: 2007.
Patsner B
Gynecol Oncol; 2008 Jan; 108(1):254-5; author reply 255. PubMed ID: 17963827
[No Abstract] [Full Text] [Related]
18. Clinical trials referral resource. Update on taxol trials.
Cheson BD
Oncology (Williston Park); 1993 Jan; 7(1):63, 66-7. PubMed ID: 8093592
[No Abstract] [Full Text] [Related]
19. Intraperitoneal chemotherapy in ovarian cancer remains experimental.
Gore M; du Bois A; Vergote I
J Clin Oncol; 2006 Oct; 24(28):4528-30. PubMed ID: 17008689
[No Abstract] [Full Text] [Related]
20. [Advanced ovarian cancer: a need for redefining therapeutic objectives and strategy].
Bugat R; Guastalla JP; Misset JL
Bull Cancer; 2005 Nov; 92(11):1003-6. PubMed ID: 16316835
[No Abstract] [Full Text] [Related]
[Next] [New Search]
